secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2022-02-10T23:59:59+00:00
Accession:  0001437749-22-002954
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

National Research Q4 revenue +10% to $38.3M, EPS $0.38; FY revenue +11% to $148.0M
--------------------------------------------------------------------------------

- Q4 2021 revenue $38.3M (+10% YoY); operating income $12.9M (+26%); diluted EPS $0.38 vs $0.32.
- Full-year 2021 revenue $148.0M (+11%); operating income $50.3M (+18%); diluted EPS $1.46 vs $1.45.
- Cash flow from operations $46.3M (up 14%); net cash position $27.8M, up from $4.1M at year-end 2020.
- Launched Health's Human Understanding Program to personalize patient care at scale.
- Continued quarterly dividend and share repurchases funded by strong cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774922002954/0001437749-22-002954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774922002954/nrc20220209_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-002954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer